• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向 E3 泛素连接酶 PJA1 增强肿瘤抑制 TGFβ 信号。

Targeting the E3 Ubiquitin Ligase PJA1 Enhances Tumor-Suppressing TGFβ Signaling.

机构信息

Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Pfizer Inc. Integrative Biotechnology Group, Pearl River, New York.

出版信息

Cancer Res. 2020 May 1;80(9):1819-1832. doi: 10.1158/0008-5472.CAN-19-3116. Epub 2020 Mar 3.

DOI:10.1158/0008-5472.CAN-19-3116
PMID:32127355
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7704101/
Abstract

RING-finger E3 ligases are instrumental in the regulation of inflammatory cascades, apoptosis, and cancer. However, their roles are relatively unknown in TGFβ/SMAD signaling. SMAD3 and its adaptors, such as β2SP, are important mediators of TGFβ signaling and regulate gene expression to suppress stem cell-like phenotypes in diverse cancers, including hepatocellular carcinoma (HCC). Here, PJA1, an E3 ligase, promoted ubiquitination and degradation of phosphorylated SMAD3 and impaired a SMAD3/β2SP-dependent tumor-suppressing pathway in multiple HCC cell lines. In mice deficient for SMAD3 ( ), PJA1 overexpression promoted the transformation of liver stem cells. Analysis of genes regulated by PJA1 knockdown and TGFβ1 signaling revealed 1,584 co-upregulated genes and 1,280 co-downregulated genes, including many implicated in cancer. The E3 ligase inhibitor RTA405 enhanced SMAD3-regulated gene expression and reduced growth of HCC cells in culture and xenografts of HCC tumors, suggesting that inhibition of PJA1 may be beneficial in treating HCC or preventing HCC development in at-risk patients. These findings provide a novel mechanism regulating the tumor suppressor function of TGFβ in liver carcinogenesis.

摘要

RING 指 E3 连接酶在炎症级联反应、细胞凋亡和癌症的调控中起着重要作用。然而,它们在 TGFβ/SMAD 信号通路中的作用相对未知。SMAD3 及其衔接蛋白(如 β2SP)是 TGFβ 信号的重要介质,调节基因表达,抑制多种癌症中的干细胞样表型,包括肝细胞癌(HCC)。在这里,E3 连接酶 PJA1 促进了磷酸化 SMAD3 的泛素化和降解,破坏了多个 HCC 细胞系中 SMAD3/β2SP 依赖性肿瘤抑制途径。在 SMAD3 缺失的小鼠( )中,PJA1 的过表达促进了肝干细胞的转化。对 PJA1 敲低和 TGFβ1 信号转导调控基因的分析显示,有 1584 个共同上调基因和 1280 个共同下调基因,包括许多与癌症相关的基因。E3 连接酶抑制剂 RTA405 增强了 SMAD3 调节的基因表达,并减少了 HCC 细胞在培养物和 HCC 肿瘤异种移植物中的生长,表明抑制 PJA1 可能有益于治疗 HCC 或预防高危患者的 HCC 发展。这些发现为调控 TGFβ 在肝致癌中的肿瘤抑制功能提供了一种新的机制。

相似文献

1
Targeting the E3 Ubiquitin Ligase PJA1 Enhances Tumor-Suppressing TGFβ Signaling.靶向 E3 泛素连接酶 PJA1 增强肿瘤抑制 TGFβ 信号。
Cancer Res. 2020 May 1;80(9):1819-1832. doi: 10.1158/0008-5472.CAN-19-3116. Epub 2020 Mar 3.
2
Selective targeting of activating and inhibitory Smads by distinct WWP2 ubiquitin ligase isoforms differentially modulates TGFβ signalling and EMT.不同的 WWP2 泛素连接酶同工型对激活型和抑制型 Smads 的选择性靶向作用,可不同程度地调节 TGFβ 信号转导和 EMT。
Oncogene. 2011 May 26;30(21):2451-62. doi: 10.1038/onc.2010.617. Epub 2011 Jan 24.
3
Induction of tolerogenic dendritic cells by activated TGF-β/Akt/Smad2 signaling in RIG-I-deficient stemness-high human liver cancer cells.RIG-I 缺陷型干性高的人肝癌细胞中激活的 TGF-β/Akt/Smad2 信号诱导免疫耐受树突状细胞。
BMC Cancer. 2019 May 14;19(1):439. doi: 10.1186/s12885-019-5670-9.
4
Upregulation of CYR61 by TGF-β and YAP signaling exerts a counter-suppression of hepatocellular carcinoma.转化生长因子-β(TGF-β)和Yes相关蛋白(YAP)信号通路对富含半胱氨酸的血管生成素61(CYR61)的上调发挥了对肝细胞癌的反抑制作用。
J Biol Chem. 2024 Apr;300(4):107208. doi: 10.1016/j.jbc.2024.107208. Epub 2024 Mar 21.
5
Transcription factor specificity protein 1-mediated Serine/threonine kinase 39 upregulation promotes the proliferation, migration, invasion and epithelial-mesenchymal transition of hepatocellular carcinoma cells by activating the transforming growth factor-β1 /Smad2/3 pathway.转录因子特异性蛋白 1 介导丝氨酸/苏氨酸激酶 39 的上调通过激活转化生长因子-β1/Smad2/3 通路促进肝癌细胞的增殖、迁移、侵袭和上皮-间充质转化。
Bioengineered. 2021 Dec;12(1):3566-3577. doi: 10.1080/21655979.2021.1947939.
6
Inhibition of the cancer stem cells-like properties by arsenic trioxide, involved in the attenuation of endogenous transforming growth factor beta signal.三氧化二砷对癌症干细胞样特性的抑制作用,涉及内源性转化生长因子β信号的减弱。
Toxicol Sci. 2015 Jan;143(1):156-64. doi: 10.1093/toxsci/kfu218. Epub 2014 Oct 10.
7
E3 ligase ZFP91 inhibits Hepatocellular Carcinoma Metabolism Reprogramming by regulating PKM splicing.E3 连接酶 ZFP91 通过调节 PKM 剪接抑制肝癌代谢重编程。
Theranostics. 2020 Jul 9;10(19):8558-8572. doi: 10.7150/thno.44873. eCollection 2020.
8
TGF-β signaling is often attenuated during hepatotumorigenesis, but is retained for the malignancy of hepatocellular carcinoma cells.TGF-β 信号在肝肿瘤发生过程中经常被削弱,但在肝癌细胞的恶性转化中仍然保留。
PLoS One. 2013 May 21;8(5):e63436. doi: 10.1371/journal.pone.0063436. Print 2013.
9
microRNA-17 functions as an oncogene by downregulating Smad3 expression in hepatocellular carcinoma.microRNA-17 通过下调肝癌中 Smad3 的表达发挥癌基因作用。
Cell Death Dis. 2019 Sep 26;10(10):723. doi: 10.1038/s41419-019-1960-z.
10
Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.转化生长因子-β 通过上调 Snail 促进小鼠肝癌发生。
Gastroenterology. 2017 Nov;153(5):1378-1391.e6. doi: 10.1053/j.gastro.2017.07.014. Epub 2017 Jul 20.

引用本文的文献

1
Platelets in cancer and immunotherapy: functional dynamics and therapeutic opportunities.癌症与免疫疗法中的血小板:功能动态与治疗机遇
Exp Hematol Oncol. 2025 Jun 13;14(1):83. doi: 10.1186/s40164-025-00676-x.
2
E3 Ubiquitin Ligases and Their Therapeutic Applications in Cancers: Narrative Review.E3泛素连接酶及其在癌症中的治疗应用:叙述性综述
J Pharm Bioallied Sci. 2024 Jul;16(Suppl 3):S1984-S1986. doi: 10.4103/jpbs.jpbs_134_24. Epub 2024 Jun 7.
3
PJA1-mediated suppression of pyroptosis as a driver of docetaxel resistance in nasopharyngeal carcinoma.PJA1 介导的细胞焦亡抑制作用是鼻咽癌多西他赛耐药的驱动因素。
Nat Commun. 2024 Jun 21;15(1):5300. doi: 10.1038/s41467-024-49675-2.
4
E3 ubiquitin ligases in cancer stem cells: key regulators of cancer hallmarks and novel therapeutic opportunities.E3 泛素连接酶在肿瘤干细胞中的作用:肿瘤标志物的关键调节因子和新的治疗机会。
Cell Oncol (Dordr). 2023 Jun;46(3):545-570. doi: 10.1007/s13402-023-00777-x. Epub 2023 Feb 6.
5
Praja1 RING-finger E3 ubiquitin ligase is a common suppressor of neurodegenerative disease-associated protein aggregation.Praja1 RING 指泛素连接酶是一种常见的神经退行性疾病相关蛋白聚集的抑制剂。
Neuropathology. 2022 Dec;42(6):488-504. doi: 10.1111/neup.12840. Epub 2022 Jun 14.
6
OTUB2 Promotes Proliferation and Migration of Hepatocellular Carcinoma Cells by PJA1 Deubiquitylation.OTUB2通过去泛素化PJA1促进肝癌细胞的增殖和迁移。
Cell Mol Bioeng. 2022 Feb 1;15(3):281-292. doi: 10.1007/s12195-022-00720-4. eCollection 2022 Jun.
7
The roles of E3 ligases in Hepatocellular carcinoma.E3 泛素连接酶在肝细胞癌中的作用。
Am J Cancer Res. 2022 Mar 15;12(3):1179-1214. eCollection 2022.
8
Praja1 ubiquitin ligase facilitates degradation of polyglutamine proteins and suppresses polyglutamine-mediated toxicity.Praja1 泛素连接酶促进多聚谷氨酰胺蛋白的降解,并抑制多聚谷氨酰胺介导的毒性。
Mol Biol Cell. 2021 Aug 15;32(17):1579-1593. doi: 10.1091/mbc.E20-11-0747. Epub 2021 Jun 23.
9
SEPHS1 promotes SMAD2/3/4 expression and hepatocellular carcinoma cells invasion.SEPHS1促进SMAD2/3/4的表达以及肝癌细胞的侵袭。
Exp Hematol Oncol. 2021 Feb 23;10(1):17. doi: 10.1186/s40164-021-00212-7.
10
Dysregulated PJA1-TGF-β signaling in cancer stem cell-associated liver cancers.癌症干细胞相关肝癌中PJA1 - TGF-β信号传导失调
Oncoscience. 2020 Nov 30;7(11-12):88-95. doi: 10.18632/oncoscience.522. eCollection 2020 Nov.

本文引用的文献

1
Inhibiting Glutamine-Dependent mTORC1 Activation Ameliorates Liver Cancers Driven by β-Catenin Mutations.抑制谷氨酰胺依赖性 mTORC1 激活可改善由β-连环蛋白突变驱动的肝癌。
Cell Metab. 2019 May 7;29(5):1135-1150.e6. doi: 10.1016/j.cmet.2019.01.002. Epub 2019 Jan 31.
2
Plant-Derived Oleanolic Acid (OA) Ameliorates Risk Factors of Cardiovascular Diseases in a Diet-Induced Pre-Diabetic Rat Model: Effects on Selected Cardiovascular Risk Factors.植物源齐墩果酸(OA)可改善饮食诱导的糖尿病前期大鼠模型的心血管疾病风险因素:对某些心血管风险因素的影响。
Molecules. 2019 Jan 18;24(2):340. doi: 10.3390/molecules24020340.
3
Epidemiology and Management of Hepatocellular Carcinoma.原发性肝癌的流行病学和管理。
Gastroenterology. 2019 Jan;156(2):477-491.e1. doi: 10.1053/j.gastro.2018.08.065. Epub 2018 Oct 24.
4
Molecular therapies and precision medicine for hepatocellular carcinoma.肝细胞癌的分子治疗和精准医学。
Nat Rev Clin Oncol. 2018 Oct;15(10):599-616. doi: 10.1038/s41571-018-0073-4.
5
Contextual determinants of TGFβ action in development, immunity and cancer.转化生长因子β(TGFβ)在发育、免疫和癌症中作用的情境决定因素。
Nat Rev Mol Cell Biol. 2018 Jul;19(7):419-435. doi: 10.1038/s41580-018-0007-0.
6
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation.机器学习鉴定与致癌去分化相关的干性特征。
Cell. 2018 Apr 5;173(2):338-354.e15. doi: 10.1016/j.cell.2018.03.034.
7
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.肝细胞癌的诊断、分期及管理:美国肝病研究协会2018年实践指南
Hepatology. 2018 Aug;68(2):723-750. doi: 10.1002/hep.29913.
8
Analysis of Genomes and Transcriptomes of Hepatocellular Carcinomas Identifies Mutations and Gene Expression Changes in the Transforming Growth Factor-β Pathway.肝细胞癌基因组和转录组分析确定了转化生长因子-β信号通路中的突变和基因表达变化。
Gastroenterology. 2018 Jan;154(1):195-210. doi: 10.1053/j.gastro.2017.09.007. Epub 2017 Sep 15.
9
Transforming Growth Factor-β Receptors and Smads: Regulatory Complexity and Functional Versatility.转化生长因子-β 受体和 Smads:调控复杂性和功能多样性。
Trends Cell Biol. 2017 Sep;27(9):658-672. doi: 10.1016/j.tcb.2017.04.005. Epub 2017 May 25.
10
Non-Smad Signaling Pathways of the TGF-β Family.转化生长因子-β家族的非Smad信号通路。
Cold Spring Harb Perspect Biol. 2017 Feb 1;9(2):a022129. doi: 10.1101/cshperspect.a022129.